Cosmos Health Inc. (NASDAQ:COSM) Short Interest Update

Cosmos Health Inc. (NASDAQ:COSM) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 189,700 shares, a decline of 53.3% from the February 29th total of 406,200 shares. Based on an average daily trading volume, of 306,100 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.3% of the company’s shares are short sold.

Analyst Ratings Changes

Separately, Taglich Brothers reiterated a “speculative buy” rating on shares of Cosmos Health in a report on Tuesday, February 20th.

Insider Transactions at Cosmos Health

In other news, CEO Grigorios Siokas purchased 60,000 shares of the stock in a transaction dated Friday, February 16th. The stock was acquired at an average cost of $0.83 per share, for a total transaction of $49,800.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,394,597 shares in the company, valued at approximately $1,157,515.51. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 18.74% of the company’s stock.

Institutional Investors Weigh In On Cosmos Health

A number of institutional investors have recently bought and sold shares of the stock. Armistice Capital LLC purchased a new stake in Cosmos Health in the fourth quarter valued at approximately $1,882,000. Vanguard Group Inc. purchased a new stake in Cosmos Health in the third quarter valued at approximately $212,000. BlackRock Inc. grew its holdings in Cosmos Health by 9.0% in the second quarter. BlackRock Inc. now owns 291,914 shares of the company’s stock valued at $873,000 after purchasing an additional 24,117 shares during the period. State Street Corp purchased a new stake in Cosmos Health in the first quarter valued at approximately $76,000. Finally, Geode Capital Management LLC purchased a new stake in Cosmos Health in the first quarter valued at approximately $327,000. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

Cosmos Health Stock Performance

Shares of NASDAQ COSM remained flat at $0.71 during midday trading on Friday. 175,528 shares of the stock were exchanged, compared to its average volume of 319,296. Cosmos Health has a 1-year low of $0.61 and a 1-year high of $4.05. The stock’s 50-day simple moving average is $0.83 and its 200 day simple moving average is $1.09. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.06 and a quick ratio of 1.79.

About Cosmos Health

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.